Recommendation of the President – MSUD Anamix Infant, MSUD Anamix Junior, MSUD Anamix Junior LQ, MSUD Gel, MSUD Cooler, MSUD Express, and MSUD Lophlex LQ
On 20 March 2026, the President of the Agency for Health Technology Assessment and Tariff System issued recommendation No. 37/2026 regarding the appropriateness of approving reimbursement for the following products: MSUD Anamix Infant, MSUD Anamix Junior, MSUD Anamix Junior LQ, MSUD Gel, MSUD Cooler, MSUD Express, and MSUD Lophlex LQ for the following indications: maple syrup urine disease, beta-ketothiolase deficiency, and 3-hydroxyisobutyrate-CoA hydrolase deficiency